Symbol:
Anxa8
Name:
annexin A8
RGD ID:
1307719
Description:
Predicted to enable several functions, including actin filament binding activity; phosphatidylinositol-3,4-bisphosphate binding activity; and phospholipid binding activity. Predicted to be involved in endosomal transport; endosome organization; and negative regulation of hydrolase activity. Predicted to be located in cytosol; late endosome membrane; and plasma membrane. Predicted to be active in cytoplasm; sarcolemma; and vesicle membrane. Orthologous to several human genes including ANXA8 (annexin A8); INTERACTS WITH (+)-schisandrin B; 17alpha-ethynylestradiol; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
annexin VIII; annexin-8; LOC306283; MGC116246
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
ANXA8 (annexin A8) RGD
RGD
Mus musculus (house mouse):
Anxa8 (annexin A8) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
ANXA8L1 (annexin A8 like 1) HGNC
Ensembl, HomoloGene, Inparanoid, Panther, PhylomeDB
Homo sapiens (human):
ANXA4 (annexin A4) HGNC
OrthoDB
Homo sapiens (human):
PLEK (pleckstrin) HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
ANXA8 (annexin A8)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Anxa8 (annexin A8)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
AnxB10
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER)
Caenorhabditis elegans (roundworm):
nex-4
Alliance
DIOPT (Ensembl Compara|OrthoFinder)
Homo sapiens (human):
ANXA8L1 (annexin A8 like 1)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 16 9,403,267 - 9,418,317 (+) NCBI GRCr8 mRatBN7.2 16 9,397,144 - 9,412,072 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 16 9,397,113 - 9,412,043 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 16 9,416,681 - 9,431,616 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 16 10,561,386 - 10,576,325 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 16 9,411,746 - 9,426,672 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 16 10,417,174 - 10,432,388 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 16 10,417,185 - 10,432,393 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 16 8,737,501 - 8,752,773 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 16 9,715,644 - 9,730,584 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 16 9,715,608 - 9,730,490 (+) NCBI Celera 16 5,797,809 - 5,812,655 (-) NCBI Celera Cytogenetic Map 16 p15 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Anxa8 Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ANXA8 mRNA] CTD PMID:31150632 Anxa8 Rat 1,2-dimethylhydrazine multiple interactions ISO Anxa8 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of ANXA8 mRNA] CTD PMID:22206623 Anxa8 Rat 1,2-dimethylhydrazine increases expression ISO Anxa8 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of ANXA8 mRNA CTD PMID:22206623 Anxa8 Rat 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ANXA8 mRNA CTD PMID:17557909 Anxa8 Rat 17alpha-ethynylestradiol multiple interactions ISO Anxa8 (Mus musculus) 6480464 [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of ANXA8 mRNA CTD PMID:37844793 Anxa8 Rat 17beta-estradiol decreases expression ISO Anxa8 (Mus musculus) 6480464 Estradiol results in decreased expression of ANXA8 mRNA CTD PMID:19484750 Anxa8 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Anxa8 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ANXA8 mRNA CTD PMID:21570461 Anxa8 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ANXA8 mRNA CTD PMID:21724226 and PMID:34747641 Anxa8 Rat 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 Anxa8 Rat 2,4,6-trinitrobenzenesulfonic acid increases expression ISO Anxa8 (Mus musculus) 6480464 Trinitrobenzenesulfonic Acid results in increased expression of ANXA8 mRNA CTD PMID:17982090 Anxa8 Rat 2,4-diaminotoluene increases expression ISO Anxa8 (Mus musculus) 6480464 2 and 4-diaminotoluene results in increased expression of ANXA8 mRNA CTD PMID:20713471 Anxa8 Rat 2-acetamidofluorene increases expression ISO Anxa8 (Mus musculus) 6480464 2-Acetylaminofluorene results in increased expression of ANXA8 mRNA CTD PMID:17317680 Anxa8 Rat 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:32119087 Anxa8 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO ANXA8 (Homo sapiens) 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of ANXA8 mRNA CTD PMID:16997883 Anxa8 Rat 3-methylcholanthrene increases expression ISO Anxa8 (Mus musculus) 6480464 Methylcholanthrene results in increased expression of ANXA8 mRNA CTD PMID:20713471 Anxa8 Rat 4,4'-sulfonyldiphenol increases expression ISO Anxa8 (Mus musculus) 6480464 bisphenol S results in increased expression of ANXA8 mRNA CTD PMID:30951980 Anxa8 Rat 4,4'-sulfonyldiphenol affects expression ISO ANXA8 (Homo sapiens) 6480464 bisphenol S affects the expression of ANXA8 protein CTD PMID:31945527 Anxa8 Rat 4-hydroxyphenyl retinamide decreases expression ISO Anxa8 (Mus musculus) 6480464 Fenretinide results in decreased expression of ANXA8 mRNA CTD PMID:28973697 Anxa8 Rat 6-propyl-2-thiouracil multiple interactions ISO Anxa8 (Mus musculus) 6480464 [Propylthiouracil co-treated with Iodine deficiency] results in increased expression of ANXA8 mRNA CTD PMID:36706583 Anxa8 Rat 7,12-dimethyltetraphene increases expression ISO Anxa8 (Mus musculus) 6480464 9 more ... CTD PMID:32553695 Anxa8 Rat 8-Br-cAMP multiple interactions ISO ANXA8 (Homo sapiens) 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of ANXA8 mRNA CTD PMID:16997883 Anxa8 Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of ANXA8 mRNA CTD PMID:31881176 Anxa8 Rat acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of ANXA8 mRNA CTD PMID:28959563 Anxa8 Rat aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ANXA8 mRNA CTD PMID:23630614 and PMID:25378103 Anxa8 Rat aflatoxin B1 increases methylation ISO ANXA8 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of ANXA8 gene CTD PMID:27153756 Anxa8 Rat all-trans-retinoic acid decreases expression ISO ANXA8 (Homo sapiens) 6480464 Tretinoin results in decreased expression of ANXA8 mRNA CTD PMID:33167477 Anxa8 Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ANXA8 mRNA CTD PMID:35163327 Anxa8 Rat arsane multiple interactions ISO ANXA8 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ANXA8 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ANXA8 mRNA CTD PMID:39836092 Anxa8 Rat arsenic atom multiple interactions ISO ANXA8 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ANXA8 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ANXA8 mRNA CTD PMID:39836092 Anxa8 Rat atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of ANXA8 mRNA CTD PMID:36841081 Anxa8 Rat benzo[a]pyrene increases expression ISO Anxa8 (Mus musculus) 6480464 Benzo(a)pyrene metabolite results in increased expression of ANXA8 mRNA CTD PMID:32553695 Anxa8 Rat benzylpenicillin decreases expression ISO ANXA8 (Homo sapiens) 6480464 Penicillin G results in decreased expression of ANXA8 mRNA CTD PMID:24737281 Anxa8 Rat beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANXA8 mRNA CTD PMID:18164116 Anxa8 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ANXA8 mRNA CTD PMID:25181051 Anxa8 Rat bisphenol A increases expression ISO Anxa8 (Mus musculus) 6480464 bisphenol A results in increased expression of ANXA8 mRNA CTD PMID:32156529 Anxa8 Rat bisphenol A decreases expression ISO Anxa8 (Mus musculus) 6480464 bisphenol A results in decreased expression of ANXA8 mRNA CTD PMID:34585602 Anxa8 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ANXA8 mRNA CTD PMID:30816183 more ... Anxa8 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ANXA8 gene CTD PMID:28505145 Anxa8 Rat bisphenol F increases expression ISO Anxa8 (Mus musculus) 6480464 bisphenol F results in increased expression of ANXA8 mRNA CTD PMID:30951980 Anxa8 Rat butan-1-ol multiple interactions ISO ANXA8 (Homo sapiens) 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ANXA8 mRNA CTD PMID:29432896 Anxa8 Rat cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of ANXA8 promoter CTD PMID:22457795 Anxa8 Rat carbon nanotube decreases expression ISO Anxa8 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of ANXA8 mRNA CTD PMID:25554681 Anxa8 Rat chloropicrin increases expression ISO ANXA8 (Homo sapiens) 6480464 chloropicrin results in increased expression of ANXA8 mRNA CTD PMID:26352163 Anxa8 Rat chloroprene increases expression ISO Anxa8 (Mus musculus) 6480464 Chloroprene results in increased expression of ANXA8 mRNA CTD PMID:23125180 Anxa8 Rat cobalt dichloride decreases expression ISO ANXA8 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of ANXA8 mRNA CTD PMID:19376846 Anxa8 Rat copper atom decreases expression EXP 6480464 Copper results in decreased expression of ANXA8 mRNA CTD PMID:30556269 Anxa8 Rat copper(0) decreases expression EXP 6480464 Copper results in decreased expression of ANXA8 mRNA CTD PMID:30556269 Anxa8 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of ANXA8 mRNA CTD PMID:27523638 Anxa8 Rat cytarabine decreases expression ISO ANXA8 (Homo sapiens) 6480464 Cytarabine results in decreased expression of ANXA8 mRNA CTD PMID:21198554 Anxa8 Rat dexamethasone multiple interactions ISO ANXA8 (Homo sapiens) 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of ANXA8 mRNA CTD PMID:16997883 Anxa8 Rat diallyl trisulfide increases expression EXP 6480464 diallyl trisulfide results in increased expression of ANXA8 mRNA CTD PMID:34014027 Anxa8 Rat dibenz[a,h]anthracene decreases expression ISO Anxa8 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 Anxa8 Rat diclofenac multiple interactions ISO Anxa8 (Mus musculus) 6480464 [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of ANXA8 mRNA CTD PMID:37844793 Anxa8 Rat diethyl phthalate decreases expression EXP 6480464 diethyl phthalate results in decreased expression of ANXA8L1 mRNA CTD PMID:32341500 Anxa8 Rat diiodine multiple interactions ISO Anxa8 (Mus musculus) 6480464 [Propylthiouracil co-treated with Iodine deficiency] results in increased expression of ANXA8 mRNA CTD PMID:36706583 Anxa8 Rat dimethylarsinic acid multiple interactions ISO Anxa8 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANXA8 mRNA CTD PMID:34876320 Anxa8 Rat dioxygen multiple interactions ISO Anxa8 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANXA8 mRNA CTD PMID:30529165 Anxa8 Rat doxifluridine decreases response to substance ISO ANXA8 (Homo sapiens) 6480464 ANXA8 protein results in decreased susceptibility to doxifluridine CTD PMID:16734730 Anxa8 Rat ethanol multiple interactions ISO ANXA8 (Homo sapiens) 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ANXA8 mRNA CTD PMID:29432896 Anxa8 Rat folic acid multiple interactions ISO Anxa8 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of ANXA8 mRNA] CTD PMID:22206623 Anxa8 Rat genistein affects expression ISO Anxa8 (Mus musculus) 6480464 Genistein affects the expression of ANXA8 mRNA CTD PMID:32186404 Anxa8 Rat ibuprofen multiple interactions ISO Anxa8 (Mus musculus) 6480464 [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of ANXA8 mRNA CTD PMID:37844793 Anxa8 Rat isobutanol multiple interactions ISO ANXA8 (Homo sapiens) 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ANXA8 mRNA CTD PMID:29432896 Anxa8 Rat lipopolysaccharide multiple interactions ISO ANXA8 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 Anxa8 Rat manganese atom multiple interactions ISO ANXA8 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ANXA8 mRNA CTD PMID:39836092 Anxa8 Rat manganese(0) multiple interactions ISO ANXA8 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ANXA8 mRNA CTD PMID:39836092 Anxa8 Rat manganese(II) chloride multiple interactions ISO ANXA8 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ANXA8 mRNA CTD PMID:39836092 Anxa8 Rat methylarsonic acid multiple interactions ISO Anxa8 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANXA8 mRNA CTD PMID:34876320 Anxa8 Rat N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANXA8 mRNA CTD PMID:18164116 Anxa8 Rat ozone multiple interactions ISO Anxa8 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ANXA8 mRNA CTD PMID:34911549 Anxa8 Rat paclitaxel increases response to substance ISO ANXA8 (Homo sapiens) 6480464 ANXA8 protein results in increased susceptibility to Paclitaxel CTD PMID:16734730 Anxa8 Rat paracetamol decreases expression ISO ANXA8 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of ANXA8 mRNA CTD PMID:29067470 Anxa8 Rat paraquat increases expression EXP 6480464 Paraquat results in increased expression of ANXA8 mRNA CTD PMID:32680482 Anxa8 Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ANXA8 mRNA CTD PMID:35163327 Anxa8 Rat phenobarbital affects expression ISO ANXA8 (Homo sapiens) 6480464 Phenobarbital affects the expression of ANXA8 mRNA CTD PMID:19159669 Anxa8 Rat potassium dichromate increases expression ISO Anxa8 (Mus musculus) 6480464 Potassium Dichromate results in increased expression of ANXA8 mRNA CTD PMID:23608068 Anxa8 Rat quercetin affects expression EXP 6480464 Quercetin affects the expression of ANXA8 mRNA CTD PMID:18178720 Anxa8 Rat S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO ANXA8 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of ANXA8 mRNA CTD PMID:35811015 Anxa8 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO ANXA8 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 Anxa8 Rat serpentine asbestos decreases expression ISO ANXA8 (Homo sapiens) 6480464 Asbestos and Serpentine results in decreased expression of ANXA8 mRNA CTD PMID:29523930 Anxa8 Rat sodium arsenate multiple interactions ISO Anxa8 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANXA8 mRNA CTD PMID:34876320 Anxa8 Rat sodium arsenite decreases expression ISO ANXA8 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of ANXA8 mRNA CTD PMID:38568856 Anxa8 Rat sodium arsenite decreases expression ISO Anxa8 (Mus musculus) 6480464 sodium arsenite results in decreased expression of ANXA8 mRNA CTD PMID:37682722 Anxa8 Rat sodium arsenite multiple interactions ISO Anxa8 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANXA8 mRNA CTD PMID:34876320 Anxa8 Rat sodium arsenite multiple interactions ISO ANXA8 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ANXA8 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ANXA8 mRNA CTD PMID:39836092 Anxa8 Rat sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of ANXA8 mRNA CTD PMID:22110744 Anxa8 Rat sulforaphane increases expression ISO Anxa8 (Mus musculus) 6480464 sulforaphane results in increased expression of ANXA8 mRNA CTD PMID:30529165 Anxa8 Rat sulforaphane decreases expression ISO ANXA8 (Homo sapiens) 6480464 sulforaphane results in decreased expression of ANXA8 mRNA CTD PMID:31838189 Anxa8 Rat tert-butyl hydroperoxide increases expression ISO Anxa8 (Mus musculus) 6480464 tert-Butylhydroperoxide results in increased expression of ANXA8 mRNA CTD PMID:14729362 and PMID:15003993 Anxa8 Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ANXA8 mRNA] CTD PMID:31150632 Anxa8 Rat tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ANXA8 mRNA CTD PMID:30723492 and PMID:31150632 Anxa8 Rat titanium dioxide affects expression ISO Anxa8 (Mus musculus) 6480464 titanium dioxide affects the expression of ANXA8 mRNA CTD PMID:23557971 Anxa8 Rat titanium dioxide increases expression ISO Anxa8 (Mus musculus) 6480464 titanium dioxide results in increased expression of ANXA8 mRNA CTD PMID:35295148 Anxa8 Rat triclosan increases expression ISO ANXA8 (Homo sapiens) 6480464 Triclosan results in increased expression of ANXA8 mRNA CTD PMID:30510588 Anxa8 Rat trimellitic anhydride increases expression ISO Anxa8 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of ANXA8 mRNA CTD PMID:19042947 Anxa8 Rat valproic acid increases methylation ISO ANXA8 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of ANXA8 gene CTD PMID:29154799 Anxa8 Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ANXA8 mRNA CTD PMID:19015723
(+)-schisandrin B (EXP) 1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (EXP,ISO) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3,7,8-Tetrachlorodibenzofuran (EXP) 2,4,6-trinitrobenzenesulfonic acid (ISO) 2,4-diaminotoluene (ISO) 2-acetamidofluorene (ISO) 3,3',4,4',5-pentachlorobiphenyl (EXP) 3-isobutyl-1-methyl-7H-xanthine (ISO) 3-methylcholanthrene (ISO) 4,4'-sulfonyldiphenol (ISO) 4-hydroxyphenyl retinamide (ISO) 6-propyl-2-thiouracil (ISO) 7,12-dimethyltetraphene (ISO) 8-Br-cAMP (ISO) acetamide (EXP) acrylamide (EXP) aflatoxin B1 (EXP,ISO) all-trans-retinoic acid (ISO) alpha-Zearalanol (EXP) arsane (ISO) arsenic atom (ISO) atrazine (EXP) benzo[a]pyrene (ISO) benzylpenicillin (ISO) beta-naphthoflavone (EXP) bisphenol A (EXP,ISO) bisphenol F (ISO) butan-1-ol (ISO) cadmium dichloride (EXP) carbon nanotube (ISO) chloropicrin (ISO) chloroprene (ISO) cobalt dichloride (ISO) copper atom (EXP) copper(0) (EXP) Cuprizon (EXP) cytarabine (ISO) dexamethasone (ISO) diallyl trisulfide (EXP) dibenz[a,h]anthracene (ISO) diclofenac (ISO) diethyl phthalate (EXP) diiodine (ISO) dimethylarsinic acid (ISO) dioxygen (ISO) doxifluridine (ISO) ethanol (ISO) folic acid (ISO) genistein (ISO) ibuprofen (ISO) isobutanol (ISO) lipopolysaccharide (ISO) manganese atom (ISO) manganese(0) (ISO) manganese(II) chloride (ISO) methylarsonic acid (ISO) N-nitrosodiethylamine (EXP) ozone (ISO) paclitaxel (ISO) paracetamol (ISO) paraquat (EXP) perfluorooctanoic acid (EXP) phenobarbital (ISO) potassium dichromate (ISO) quercetin (EXP) S-(1,2-dichlorovinyl)-L-cysteine (ISO) serpentine asbestos (ISO) sodium arsenate (ISO) sodium arsenite (ISO) sodium dichromate (EXP) sulforaphane (ISO) tert-butyl hydroperoxide (ISO) tetrachloromethane (EXP) titanium dioxide (ISO) triclosan (ISO) trimellitic anhydride (ISO) valproic acid (ISO) vinclozolin (EXP)
Anxa8 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 16 9,403,267 - 9,418,317 (+) NCBI GRCr8 mRatBN7.2 16 9,397,144 - 9,412,072 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 16 9,397,113 - 9,412,043 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 16 9,416,681 - 9,431,616 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 16 10,561,386 - 10,576,325 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 16 9,411,746 - 9,426,672 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 16 10,417,174 - 10,432,388 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 16 10,417,185 - 10,432,393 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 16 8,737,501 - 8,752,773 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 16 9,715,644 - 9,730,584 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 16 9,715,608 - 9,730,490 (+) NCBI Celera 16 5,797,809 - 5,812,655 (-) NCBI Celera Cytogenetic Map 16 p15 NCBI
ANXA8 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 10 47,467,993 - 47,991,796 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 10 47,460,162 - 47,484,158 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 10 48,255,247 - 48,271,369 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 10 47,875,231 - 47,891,375 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 10 47,217,012 - 47,233,044 NCBI Cytogenetic Map 10 q11.22 NCBI HuRef 10 43,018,066 - 43,029,984 (+) NCBI HuRef CHM1_1 10 48,417,242 - 48,433,403 (+) NCBI CHM1_1 T2T-CHM13v2.0 10 48,359,294 - 48,840,973 (-) NCBI T2T-CHM13v2.0
Anxa8 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 14 33,807,936 - 33,822,528 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 14 33,807,938 - 33,822,528 (+) Ensembl GRCm39 Ensembl GRCm38 14 34,085,979 - 34,100,571 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 14 34,085,981 - 34,100,571 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 14 34,899,176 - 34,913,757 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 14 32,915,077 - 32,929,663 (+) NCBI MGSCv36 mm8 MGSCv36 14 29,195,890 - 29,210,476 (+) NCBI MGSCv36 mm8 Celera 14 30,348,562 - 30,363,455 (+) NCBI Celera Cytogenetic Map 14 B NCBI cM Map 14 20.8 NCBI
.
Predicted Target Of
Count of predictions: 330 Count of miRNA genes: 205 Interacting mature miRNAs: 233 Transcripts: ENSRNOT00000027464 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
631561 Hcuc2 Hepatic copper content QTL 2 2.8 liver copper amount (VT:0003065) liver total copper weight (CMO:0001507) 16 1 39533949 Rat 1582235 Insul8 Insulin level QTL 8 3.3 0.0063 blood insulin amount (VT:0001560) calculated serum insulin level (CMO:0000359) 16 1 26727669 Rat 2307172 Activ4 Activity QTL 4 3.71 0.00023 locomotor behavior trait (VT:0001392) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 16 1 33418960 Rat 1354584 Despr6 Despair related QTL 6 3.1 0.0067 locomotor behavior trait (VT:0001392) amount of time spent in voluntary immobility (CMO:0001043) 16 1 39533930 Rat 1357403 Slep4 Serum leptin concentration QTL 4 3.91 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 16 1 9639137 Rat 2302380 Slep6 Serum leptin concentration QTL 6 3.36 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 16 1 32139025 Rat 737819 Hcas4 Hepatocarcinoma susceptibility QTL 4 4.43 liver integrity trait (VT:0010547) volume of individual liver tumorous lesion (CMO:0001078) 16 4227609 46975965 Rat 9590151 Scort8 Serum corticosterone level QTL 8 8.45 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 16 1 30836262 Rat 1354625 Despr7 Despair related QTL 7 3.16 0.016 locomotor behavior trait (VT:0001392) amount of time spent in voluntary immobility (CMO:0001043) 16 1 44977551 Rat 61338 Bp23 Blood pressure QTL 23 4.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 16 4227609 49227609 Rat 61405 Niddm6 Non-insulin dependent diabetes mellitus QTL 6 3.66 0.001 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 16 4227609 48972724 Rat 631830 Alc7 Alcohol consumption QTL 7 2.9 consumption behavior trait (VT:0002069) ethanol drink intake rate (CMO:0001407) 16 1 26727669 Rat 7411664 Foco30 Food consumption QTL 30 11 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 16 1 44588133 Rat 1600378 Arunc4 Aerobic running capacity QTL 4 0.03 exercise endurance trait (VT:0002332) maximum distance run on treadmill (CMO:0001406) 16 380245 80345693 Rat 70183 BpQTLcluster13 Blood pressure QTL cluster 13 3.654 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 16 4227609 43025077 Rat 1600369 Hcas8 Hepatocarcinoma susceptibility QTL 8 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 16 1 22477621 Rat 737826 Alc11 Alcohol consumption QTL 11 3.2 consumption behavior trait (VT:0002069) ethanol drink intake rate (CMO:0001407) 16 4227609 60252231 Rat 737825 Alc13 Alcohol consumption QTL 13 4.5 consumption behavior trait (VT:0002069) ethanol drink intake rate (CMO:0001407) 16 4227609 16039848 Rat 2303566 Bw90 Body weight QTL 90 2 body mass (VT:0001259) body weight (CMO:0000012) 16 1 39533930 Rat 2312663 Slep9 Serum leptin concentration QTL 9 0.001 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 16 832236 59492508 Rat 2306902 Bp339 Blood pressure QTL 339 0.01 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 16 3380150 43025077 Rat 1300133 Rf24 Renal function QTL 24 3.64 blood creatinine amount (VT:0005328) creatinine clearance (CMO:0000765) 16 3380150 21361552 Rat 2312660 Bw95 Body weight QTL 95 0.05 inguinal fat pad mass (VT:0010424) inguinal fat pad weight to body weight ratio (CMO:0001253) 16 832236 59492508 Rat 2312666 Insul16 Insulin level QTL 16 0.01 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 16 832236 59492508 Rat 634355 Rends4 Renal damage susceptibility QTL 4 0.05 kidney blood vessel morphology trait (VT:0000530) organ lesion measurement (CMO:0000677) 16 1 26727669 Rat 61372 Bp40 Blood pressure QTL 40 2.2 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 16 4227730 17696785 Rat 2293343 Glom16 Glomerulus QTL 16 7.4 kidney glomerulus integrity trait (VT:0010546) kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269) 16 832236 46053497 Rat 2301406 Kidm39 Kidney mass QTL 39 0.002 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 16 2851709 15884239 Rat 6903319 Bw114 Body weight QTL 114 2.7 0.0037 body mass (VT:0001259) body weight (CMO:0000012) 16 1 43534949 Rat 2312669 Stl23 Serum triglyceride level QTL 23 0.01 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 16 832236 59492508 Rat
RH141108
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 16 9,411,680 - 9,411,860 (+) MAPPER mRatBN7.2 Rnor_6.0 16 10,431,997 - 10,432,176 NCBI Rnor6.0 Rnor_5.0 16 8,752,382 - 8,752,561 UniSTS Rnor5.0 RGSC_v3.4 16 9,730,193 - 9,730,372 UniSTS RGSC3.4 Celera 16 5,798,021 - 5,798,200 UniSTS RH 3.4 Map 10 157.6 UniSTS Cytogenetic Map 16 p16 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
110
89
88
57
25
57
6
214
95
90
45
58
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000082186 ⟹ ENSRNOP00000069969
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 16 9,397,113 - 9,412,043 (+) Ensembl Rnor_6.0 Ensembl 16 10,417,185 - 10,432,393 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000111644 ⟹ ENSRNOP00000087636
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 16 9,401,388 - 9,412,043 (+) Ensembl
RefSeq Acc Id:
NM_001031654 ⟹ NP_001026824
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 16 9,403,387 - 9,418,317 (+) NCBI mRatBN7.2 16 9,397,144 - 9,412,072 (+) NCBI Rnor_6.0 16 10,417,275 - 10,432,388 (+) NCBI Rnor_5.0 16 8,737,501 - 8,752,773 (+) NCBI RGSC_v3.4 16 9,715,644 - 9,730,584 (+) RGD Celera 16 5,797,809 - 5,812,655 (-) RGD
Sequence:
CTGTGAGGCACACAGGATGGCCTGGTGGAAAGCCTGGGTTGAACAAGAGGGCGTCAGTGTGAAGGGTAGTTCTCATTTCAACCCAGACCCTGATGCAGAGACCCTCTACAAAGCCATGAAGGGGATCG
hide sequence
RefSeq Acc Id:
XM_039094474 ⟹ XP_038950402
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 16 9,403,332 - 9,417,846 (+) NCBI mRatBN7.2 16 9,397,616 - 9,412,072 (+) NCBI
RefSeq Acc Id:
XM_063275365 ⟹ XP_063131435
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 16 9,403,267 - 9,417,846 (+) NCBI
RefSeq Acc Id:
NP_001026824 ⟸ NM_001031654
- UniProtKB:
Q4FZU6 (UniProtKB/Swiss-Prot), A0A8I6A7L2 (UniProtKB/TrEMBL)
- Sequence:
MAWWKAWVEQEGVSVKGSSHFNPDPDAETLYKAMKGIGTNEQAIIDVLTKRSNVQRQQIAKSFKAQFGKDLTETLKSELSGKFERLIVALMYPPYRYEAKELHDAMKGLGTKEGVIIEILASRTKNQL
hide sequence
Ensembl Acc Id:
ENSRNOP00000069969 ⟸ ENSRNOT00000082186
RefSeq Acc Id:
XP_038950402 ⟸ XM_039094474
- Peptide Label:
isoform X2
- UniProtKB:
A0A8I6A7L2 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000087636 ⟸ ENSRNOT00000111644
RefSeq Acc Id:
XP_063131435 ⟸ XM_063275365
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I6A7L2 (UniProtKB/TrEMBL)
RGD ID: 13699954 Promoter ID: EPDNEW_R10478 Type: initiation region Name: Anxa8_1 Description: annexin A8 SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 16 10,417,213 - 10,417,273 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2005-12-06
Anxa8
annexin A8
Anxa8_predicted
annexin A8 (predicted)
Symbol and Name updated
1559027 APPROVED
2005-01-12
Anxa8_predicted
annexin A8 (predicted)
Symbol and Name status set to approved
70820 APPROVED
